Albany Molecular Research Inc
AMRI
AMRI was delisted on the 31st of August, 2017.
143 hedge funds and large institutions have $556M invested in Albany Molecular Research Inc in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 42 reducing their positions, and 10 closing their positions.
493% more call options, than puts
Call options by funds: $1.81M | Put options by funds: $306K
120% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 10
31% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 42
9% more funds holding
Funds holding: 131 → 143 (+12)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
17% less capital invested
Capital invested by funds: $669M → $556M (-$113M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$10.2M |
| 2 |
AAM
AMI Asset Management
Los Angeles,
California
|
+$7.73M |
| 3 |
Morgan Stanley
New York
|
+$4.83M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.81M |
| 5 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
+$3.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$32M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$16.2M |
| 3 |
BM
Bridger Management
New York
|
-$11.3M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.74M |
| 5 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
-$3.36M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
151
State of Tennessee, Department of Treasury
Nashville,
Tennessee
| – | -$378K | -18,700 | Closed |
|
|
CI
152
Cowen Inc
New York
| – | -$282K | -13,958 | Closed |
|
153
Citigroup
New York
| – | -$53.8K | -2,640 | -100% |
|
AMRI Hedge Fund Activity: Q3 2015 in Review
143 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q3 2015, worth a combined $556M — down 17% from $669M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new AMRI positions and 10 closed out — a net gain of 12 holders — while 55 added to existing stakes and 42 trimmed.
The largest buyer was Clough Capital Partners, opening a new position worth an estimated $10.2M. The largest seller was Goldman Sachs, cutting an estimated $32M.
- 143 institutional investors held Albany Molecular Research Inc (AMRI) as of Q3 2015, up from 131 in Q2 2015.
- Funds reported $556M of Albany Molecular Research Inc stock for Q3 2015, down 17% quarter-over-quarter.
- 22 funds opened new Albany Molecular Research Inc positions in Q3 2015 and 10 closed out, a net change of +12 holders.
- The largest Albany Molecular Research Inc buyer in Q3 2015 was Clough Capital Partners, an estimated $10.2M added.
- The largest Albany Molecular Research Inc seller in Q3 2015 was Goldman Sachs, an estimated $32M sold.
Based on aggregated 13F filings for Q3 2015.